Skip to content
PoliticalRepoPoliticalRepo

Subjects · US

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

551 records in US in 2026

Records

Bill· HRH.R. 8425 (119th)referred

Strengthening the Vaccines for Children Program Act of 2026

United States · United States Congress · 21 April 2026

Strengthening the Vaccines for Children Program Act of 2026 This bill expands vaccination programs and coverage for children under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, the bill expands and otherwise modifies the Vaccines for Children Program, which provides free vaccinations to individuals 18 years of age or younger who are uninsured or underinsured (i.e., with limited or no insurance for vaccines), are eligible for Medicaid, or are American Indians or Alaskan Natives. The bill expands the program to include children enrolled in CHIP. The Government Accountability Office must report on the related effects of the bill's changes. The bill also temporarily requires payments under Medicaid and CHIP for vaccine administration and counseling services for children to be made at a rate that is no less than the rate under Medicare for equivalent services. It also increases the Federal Medical Assistance Percentage (i.e., federal matching rate) for states that conduct culturally appropriate outreach regarding the benefits of vaccinations for children.

Bill· HRH.R. 8414 (119th)referred

DAIRY PRIDE Act

United States · United States Congress · 21 April 2026

Bill· HRH.R. 8386 (119th)referred

RECOVER Act of 2026

United States · United States Congress · 20 April 2026

Bill· SS. 4323 (119th)referred

Ensuring Access to Lower-Cost Medicines for Seniors Act

United States · United States Congress · 16 April 2026

Ensuring Access to Lower-Cost Medicines for Seniors Act This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies. Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.

Bill· HRH.R. 8347 (119th)reported

RURAL Healthcare Act

United States · United States Congress · 16 April 2026

Resolution· HRESH.Res. 1182 (119th)passed

Expressing support for rural communities across the United States as stewards of the environment, major suppliers of United States energy resources, critical providers of food production and manufacturing capacity, and drivers of national economic stability, and recognizing the work of the House of Representatives in the 119th Congress in support of those vital communities.

United States · United States Congress · 16 April 2026

This resolution states that the House of Representatives has demonstrated support for U.S. prosperity and economic growth, especially in rural communities, through policies related to energy, health care, manufacturing, and broadband connectivity.

Bill· HRH.R. 8293 (119th)referred

Abolish the CMMI Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8317 (119th)referred

Tech to Save Moms Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8271 (119th)referred

ICU Bed Act of 2026

United States · United States Congress · 14 April 2026

Bill· HRH.R. 8261 (119th)referred

Chronic Care Management Improvement Act of 2026

United States · United States Congress · 14 April 2026

Chronic Care Management Improvement Act of 2026 This bill eliminates cost-sharing for chronic care management services under Medicare.

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 8209 (119th)open

To amend the Public Health Service Act to reauthorize the school-based health centers grant program.

United States · United States Congress · 6 April 2026

This bill reauthorizes through FY2031 grants from the Health Resources and Services Administration for school-based health centers. School-based health centers are health clinics that are located in or near school facilities, provide primary health care services to children and adolescents during school hours, and are administered by a hospital or certain public or nonprofit entities.

PreviousPage 11 of 12Next